Taken together, these results support further clinical studies on the therapeutic efficacy of cryopass-laser melatonin treatment in human tumors, and, in particular, on the therapeutic potential of inhibitors of SIRT1 toward prostate cancer. Here, SIRT1 is linked to prostate cancer.